Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • World
  • Unraveling the developmental and evolutionary constraints on sleep

Is Embryonic Evolution’s pace associated with differences in protein stability?

Light: The new weapon in the battle against Parkinson’s disease!

Unraveling the developmental and evolutionary constraints on sleep
  • World

Unraveling the developmental and evolutionary constraints on sleep

bioxone September 19, 2020September 19, 2020

-Anwita Sarkar, Team bioXone

Thomas Dekker once popularly remarked that “Sleep is the golden chain that binds health and our bodies together”. Dekker’s statement was indeed a true one. Modern-day living across the world does not embrace the importance of sleep and has taken its functions and needs for granted. The necessity of sleep can be determined by two of the most leading hypothesis that sleep prevents neuronal damage and reorganize neural networks necessary for maintaining synaptic homeostasis.

A study was conducted to create a novel mechanistic framework that can be used to quantitatively compare sleep ontogeny with sleep phylogeny. It was also used to distinguish between sleep used for neural reorganization versus repair. An abrupt sharp transition was observed between 2 and 3 years of age in humans. Results revealed that neural reorganization supporting learning is primarily due to changes in the sleep during early ontogeny ( before 2 or 3 years)while the repair is supported by differences in sleep across the phylogeny and after 2 or 3 years in a human.

Moreover, there is substantial evidence that infants spend more time in REM (rapid eye movement) sleep compared with older children and adults. This finding suggests that REM is crucial for neuroplastic reorganization. Thus the generation of this novel theory, compiling the data of sleep and brain development suggests a complex interplay between developmental and evolutionary constraints on sleep.

Source: Cao Junyu, Herman B Alexander, West B Geoffrey, Poe Gina, Savage M Van Unraveling why we sleep: Quantitative analysis reveals abrupt transition from neural reorganization to repair in early development, Science Advances  18 Sep 2020: Vol. 6, no. 38, D.O.I : http://10.1126/sciadv.aba0398.

For more news updates, please visit https://bioxone.in//

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged bioxone evolutionary constraints evolutionary constraints of sleep neural network neural reorganization versus repair neuronal damage sleep US USA

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • World

Light: The new weapon in the battle against Parkinson’s disease!

bioxone September 20, 2020

–Richismita Hazra, Amity University Kolkata From alleviating depression to healing wounds from curing sleep-disturbances to boosting immunity, light therapy finds considerable applications in the medical field. But can it relate itself to the symptoms of “shaking palsy”-Parkinson’s disease? Neurosurgeon Alim-Louis Benabid of the Climate Institute led a team that expects light to be a weapon […]

Parkinson’s disease

Related Post

  • BiotechToday
  • World

Mutant Genes Acting aid in Inter-Kingdom Genetic Transfer

BioTech Today July 18, 2021July 18, 2021

Mahek Sharan, Institute of Applied Medicines and Research, Ghaziabad Recently, a group of researchers of Hiroshima University published their work in Frontiers of Microbiology. They discovered that few bacteria like E.coli can aid genetic transfer of the plasmid via genes to different species and taxonomic kingdoms like Fungi and Protista. They studied in detail the […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Increasing life expectancy in cancer patients

bioxone July 9, 2021July 8, 2021

Husna, Amity University Kolkata Over the past decade, the rate of cancer survival has increased. China has about one-fifth of global cancer cases, and the life expectancy of cancer patients ranges from 2.4 to 11.2 years, according to the data from the population study. Based on published studies, efforts to reduce morbidity and mortality of […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Zolgensma: World’s most expensive life-saving drug approved

bioxone March 11, 2021March 11, 2021

Husna, Amity University Kolkata United Kingdom’s National Health Service (NHS) has approved the most expensive drug of ₹18 crores (£1.79 million) per dose to cure a rare genetic disorder. The drug Zolgensma, manufactured by Novartis Gene Therapies can treat Spinal Muscular Atrophy (SMA) which is a rare and often fatal genetic disease that causes paralysis […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy